Financials
- Market Capitalization 282.2 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.7
Fiyat/satışlar oranı
0.05
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3378 | ALXO ALX Oncology Holdings Inc. - Common Stock | 2.02 USD | -1.46% | -0.98% | +2.54% | +77.19% | 279.32 M USD | ||
| 3379 | TRDA Entrada Therapeutics, Inc. - Common Stock | 7.27 USD | +3.86% | -4.84% | +25.78% | +4.30% | 283.07 M USD | ||
| 3399 | ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 3.88 USD | -0.26% | -1.77% | -15.65% | +116.76% | 278.09 M USD | ||
| 3400 | NMRA Neumora Therapeutics, Inc. - Common Stock | 1.48 USD | -5.13% | -1.99% | -12.43% | -15.43% | 278.09 M USD |